Glucagon‐like peptide‐1 is involved in fasting and postprandial blood flow regulation of subcutaneous adipose tissue

Abstract Aims Glucagon-like peptide 1 (GLP-1) is a gastrointestinal hormone with pleiotropic functions, including vasodilatory and vasculoprotective effects. As GLP-1 increases after a meal, it could be involved in adipose tissue blood flow (ATBF) regulation. In one-third of healthy people, the postprandial ATBF response to meals is blunted. Whether this responder/non-responder phenomenon stems from an […]

Opinion: STAT+: How to evaluate GLP-1s and Medicare costs? Here’s one idea

Today, more than 40% of adults over 60 are considered obese, fueling chronic disease and straining Medicare’s budget. With the price tag for obesity-related care rising, some experts suggest covering GLP-1 medications for weight loss through Medicare could save billions, citing data that estimates Medicare spending could drop by $1,262 to $5,442 annually per beneficiary […]

🧪Decoding GLP-1 Scams: A Consumer’s Guide

This post is to make alerts consumers to various deceptive practices surrounding GLP-1 medications, which are often used for weight loss and diabetes management. It highlights risks associated with unregulated compounded injections from online clinics, stressing that only FDA-approved drugs from licensed pharmacies are proven safe. The guide also exposes false claims made by oral supplements, sprays, […]